Your browser doesn't support javascript.
loading
Comparing efficacy and safety of high-dose and standard-dose rifampicin in the treatment of brucellosis: a randomized clinical trial.
Salehi, Mohammadreza; Farbod, Farnaz; Khalili, Hossein; Rahmani, Hamid; Jafari, Sirous; Abbasi, Ali.
Afiliação
  • Salehi M; Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Farbod F; Department of Infectious Diseases, Tehran University of Medical Sciences, Tehran, Iran.
  • Khalili H; Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Imam Khomeini Hospital Complex, Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Rahmani H; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Jafari S; Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Abbasi A; Department of Infectious Diseases, Tehran University of Medical Sciences, Tehran, Iran.
J Antimicrob Chemother ; 78(4): 1084-1091, 2023 04 03.
Article em En | MEDLINE | ID: mdl-36880215
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Brucelose Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Brucelose Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article